dc.creatorWestermeier, Francisco
dc.creatorSáez, Pablo J.
dc.creatorVillalobos-Labra, Roberto
dc.creatorSobrevia, Luis
dc.creatorFarías-Jofré, Marcelo
dc.date.accessioned2019-03-15T16:06:51Z
dc.date.available2019-03-15T16:06:51Z
dc.date.created2019-03-15T16:06:51Z
dc.date.issued2014
dc.identifierBioMed Research International, Volumen 2014,
dc.identifier23146141
dc.identifier23146133
dc.identifier10.1155/2014/917672
dc.identifierhttps://repositorio.uchile.cl/handle/2250/166222
dc.description.abstractThe global epidemics of obesity during pregnancy and excessive gestational weight gain (GWG) are major public health problems worldwide. Obesity and excessive GWG are related to several maternal and fetal complications, including diabetes (pregestational and gestational diabetes) and intrauterine programming of insulin resistance (IR). Maternal obesity (MO) and neonatal IR are associated with long-term development of obesity, diabetes mellitus, and increased global cardiovascular risk in the offspring. Multiple mechanisms of insulin signaling pathway impairment have been described in obese individuals, involving complex interactions of chronically elevated inflammatory mediators, adipokines, and the critical role of the endoplasmic reticulum (ER) stress-dependent unfolded protein response (UPR). However, the underlying cellular processes linking MO and IR in the offspring have not been fully elucidated. Here, we summarize the state-of-the-art evidence supporting the possibility that ad
dc.languageen
dc.publisherHindawi Publishing Corporation
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceBioMed Research International
dc.subjectBiochemistry, Genetics and Molecular Biology (all)
dc.subjectImmunology and Microbiology (all)
dc.titleProgramming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución